CoChat

Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs)

Open access
Martineau, Adrian R, MacLaughlin, Beverley D, Hooper, Richard L, Barnes, Neil C, Jolliffe, David A, Greiller, Claire L, Kilpin, Kate, McLaughlin, David, Fletcher, Gareth, Mein, Charles A, Hoti, Mimoza, Walton, Robert, Grigg, Jonathan, Timms, Peter M, Rajakulasingam, Raj K, Bhowmik, Angshu, Rowe, Marion, Venton, Timothy R, Choudhury, Aklak B, Simcock, David E, Sadique, Zia, Monteiro, William R, Corrigan, Christopher J, Hawrylowicz, Catherine M, Griffiths, Christopher J · 2015 · Thorax
Cited by 122

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

RATIONALE: Asthma exacerbations are commonly precipitated by viral upper respiratory infections (URIs). Vitamin D insufficiency associates with susceptibility to URI in patients with asthma. Trials of vitamin D in adults with asthma with incidence of exacerbation and URI as primary outcome are lacking. OBJECTIVE: To conduct a randomised controlled trial of vitamin D3 supplementation for the prevention of asthma exacerbation and URI (coprimary outcomes). MEASUREMENTS AND METHODS: 250 adults with asthma in London, UK were allocated to receive six 2-monthly oral doses of 3 mg vitamin D3 (n=125) or placebo (n=125) over 1 year. Secondary outcomes included asthma control test and St George's Respiratory Questionnaire scores, fractional exhaled nitric oxide and concentrations of inflammatory markers in induced sputum. Subgroup analyses were performed to determine whether effects of supplementation were modified by baseline vitamin D status or genotype for 34 single nucleotide polymorphisms in 11 vitamin D pathway genes. MAIN RESULTS: 206/250 participants (82%) were vitamin D insufficient at baseline. Vitamin D3 did not influence time to first severe exacerbation (adjusted HR 1.02, 95% CI 0.69 to 1.53, p=0.91) or first URI (adjusted HR 0.87, 95% CI 0.64 to 1.16, p=0.34). No clinically important effect of vitamin D3 was seen on any of the secondary outcomes listed above. The influence of vitamin D3 on coprimary outcomes was not modified by baseline vitamin D status or genotype. CONCLUSIONS: Bolus-dose vitamin D3 supplementation did not influence time to exacerbation or URI in a population of adults with asthma with a high prevalence of baseline vitamin D insufficiency. TRIAL REGISTRATION NUMBER: NCT00978315 (ClinicalTrials.gov).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/thoraxjnl-2014-206449

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 122

Metadata

Authors
Martineau, A. R., MacLaughlin, B. D., Hooper, R. L., Barnes, N. C., Jolliffe, D. A., Greiller, C. L., Kilpin, K., McLaughlin, D., Fletcher, G., Mein, C. A., Hoti, M., Walton, R., Grigg, J., Timms, P. M., Rajakulasingam, R. K., Bhowmik, A., Rowe, M., Venton, T. R., Choudhury, A. B., Simcock, D. E., Sadique, Z., Monteiro, W. R., Corrigan, C. J., Hawrylowicz, C. M., & Griffiths, C. J.
Venue
Thorax
Publisher
BMJ
Published
2015-02-27
Volume
70
Issue
5
Pages
451-457
ISSN
  • 0040-6376 (ISSN-L)
  • 1468-3296
OpenAlex
W2144422991
Cited by
122
References
4
FWCI
13.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs). https://app.cochat.ai/papers/10.1136/thoraxjnl-2014-206449
The paper
Martineau, A. R., MacLaughlin, B. D., Hooper, R. L., Barnes, N. C., Jolliffe, D. A., Greiller, C. L., Kilpin, K., McLaughlin, D., Fletcher, G., Mein, C. A., Hoti, M., Walton, R., Grigg, J., Timms, P. M., Rajakulasingam, R. K., Bhowmik, A., Rowe, M., Venton, T. R., Choudhury, A. B., . . . Griffiths, C. J. (2015). Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs). Thorax. https://doi.org/10.1136/thoraxjnl-2014-206449

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.